AquaBounty Technologies, Inc. (AQB) Bundle
An Overview of AquaBounty Technologies, Inc. (AQB)
General Summary of AquaBounty Technologies, Inc. (AQB)
AquaBounty Technologies, Inc. is a biotechnology company focused on developing genetically engineered salmon for aquaculture. Founded in 1991, the company is headquartered in Maynard, Massachusetts.
Key products and services include:
- AquAdvantage Salmon - genetically modified Atlantic salmon
- Aquaculture biotechnology research and development
- Genetic engineering services for aquatic species
Financial Performance in Latest Reporting Period
| Financial Metric | 2023 Value |
|---|---|
| Total Revenue | $4.2 million |
| Net Loss | $14.3 million |
| Cash and Cash Equivalents | $22.1 million |
Industry Leadership
Market Position: AquaBounty is a pioneering company in genetically engineered aquaculture, with the first FDA-approved genetically modified salmon for human consumption.
Key operational details:
- Nasdaq-listed company (AQBU)
- Operational facilities in United States and Canada
- Unique biotechnology platform in aquaculture
| Production Metric | 2023 Data |
|---|---|
| Salmon Production Capacity | 250 metric tons per year |
| Research Investment | $5.6 million |
Mission Statement of AquaBounty Technologies, Inc. (AQB)
Mission Statement Overview
AquaBounty Technologies, Inc. (AQB) mission statement focuses on sustainable aquaculture and genetic innovation in salmon production.
Core Mission Components
| Component | Specific Details | 2024 Metrics |
|---|---|---|
| Sustainable Aquaculture | Land-based salmon farming | 3 production facilities operational |
| Genetic Innovation | AquAdvantage® Salmon development | FDA approved genetic modification |
| Environmental Responsibility | Reduced carbon footprint | 90% less water usage compared to traditional salmon farming |
Strategic Mission Elements
- Produce genetically engineered salmon
- Reduce environmental impact of aquaculture
- Increase global food production efficiency
Technological Capabilities
AquaBounty's technological platform enables 33% faster growth rates for salmon compared to traditional farming methods.
| Production Metric | 2024 Performance |
|---|---|
| Annual Production Capacity | 1,200 metric tons |
| Genetic Modification Efficiency | 99.8% genetic stability |
| Land Use Efficiency | 10x more production per acre |
Financial Context
AquaBounty reported $12.4 million revenue in 2023, with projected growth targeting $20 million in 2024.
Vision Statement of AquaBounty Technologies, Inc. (AQB)
Vision Statement of AquaBounty Technologies, Inc. (AQB)
Global Sustainable Aquaculture LeadershipAquaBounty Technologies, Inc. aims to revolutionize global aquaculture through genetically engineered salmon production. As of 2024, the company focuses on addressing global protein demands through innovative biotechnology solutions.
Key Vision Components
Sustainable Protein ProductionProduction metrics for AquaBounty's genetically modified salmon:
| Metric | 2024 Data |
|---|---|
| Annual Production Capacity | 5,000 metric tons |
| Growth Rate Improvement | 40% faster than conventional salmon |
| Feed Conversion Ratio | 1.2:1 |
- Genetic modification reducing time-to-market
- Land-based aquaculture systems
- Reduced environmental footprint
Strategic Vision Metrics
Market Penetration Goals| Market Segment | 2024 Target |
|---|---|
| North American Market Share | 12% |
| Global Sustainable Seafood Market | $3.5 million projected revenue |
- 90% reduction in marine resource usage
- 75% lower carbon emissions compared to traditional salmon farming
- Zero discharge aquaculture systems
Core Values of AquaBounty Technologies, Inc. (AQB)
Core Values of AquaBounty Technologies, Inc. (AQB)
Sustainable Aquaculture Innovation
AquaBounty Technologies demonstrates commitment to sustainable aquaculture through genetically engineered salmon production.
| Innovation Metric | 2024 Data |
|---|---|
| R&D Investment | $4.2 million |
| Genetic Modification Patents | 12 active patents |
Environmental Responsibility
The company prioritizes minimal environmental impact through controlled aquaculture practices.
- Land-based farming reduces ocean ecosystem disruption
- Closed containment systems prevent genetic contamination
- 100% sterile fish production
Scientific Integrity
AquaBounty maintains rigorous scientific standards in genetic engineering.
| Scientific Compliance Metric | 2024 Status |
|---|---|
| FDA Approvals | 2 active approvals |
| Independent Research Collaborations | 3 active partnerships |
Technological Advancement
Continuous investment in cutting-edge aquaculture technologies.
- Genetic growth optimization techniques
- Advanced breeding programs
- Precision biotechnology applications
Transparency and Ethical Practice
Commitment to clear communication and ethical biotechnology development.
| Transparency Indicator | 2024 Metrics |
|---|---|
| Public Disclosure Reports | 4 annual reports |
| Regulatory Compliance Audits | 2 successful third-party audits |
AquaBounty Technologies, Inc. (AQB) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.